Using data from the National Health Research Institute database, we determined the outcomes of 1,287 dialysis patients who underwent initial coronary revascularization between 1997 and聽2008.
The 7-year overall survival rates were 69 卤 4%, 68 卤 3%, and 57 卤 2% for the CABG, stent, and PTCA patients (p聽= 0.001), respectively. After demographic and comorbidity adjustment, hazard ratios (HRs) for all-cause death in the CABG (vs. PTCA) and stent (vs. PTCA) patients were 0.695 (p聽= 0.015) and 0.721 (p聽= 0.009). Additionally, no significant difference in all-cause death was found between the CABG and stent patients. Moreover, the 鈮?5-year-old CABG group patients and the <65-year-old coronary stent group patients showed better survival than the PTCA group patients. Compared with the PTCA and CABG groups, the coronary stent group was significantly associated with a higher risk for recurrent acute myocardial infarction (AMI). Based on age stratification, the 鈮?5-year-old stent group had a higher risk for recurrent AMI than the PTCA group (HR, 1.562; p聽= 0.026).
Chinese patients undergoing dialysis who underwent CABG or coronary stenting had better survival than those who underwent PTCA. Moreover, being 鈮?5 years old, CABG shows better survival compared with PTCA; being <65 years old, coronary stenting show better survival compared with PTCA.